Hi [[ session.user.profile.firstName ]]

Beckman Coulter

  • Date
  • Rating
  • Views
  • How do you Decide Whom to Biopsy for Prostate Cancer?
    How do you Decide Whom to Biopsy for Prostate Cancer? Dr. E. David Crawford Recorded: Feb 17 2017 61 mins
    In our webinar, Identifying Men with Prostate Cancer—The Role of phi and Other Biomarkers, Dr. E. David Crawford will discuss key issues that challenge a physician's ability to make informed decisions regarding whom to biopsy for prostate cancer. After the webinar, you will be able to:

    • Understand the historical perspective and controversy regarding prostate-specific antigen (PSA) screening

    • Improve your interpretation of a PSA result

    • Use biomarkers, such as Prostate Health Index (phi), to reduce negative biopsies and have more confidence in the decision to biopsy

    • Understand how the phi score, combined with family and patient history, can determine patient management decisions

    Dr. Crawford is an internationally renowned urologist and distinguished endowed professor of surgery, urology and radiation oncology. He also serves as the head of the section of urologic oncology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado. Dr. Crawford received his medical degree from the University of Cincinnati. His postgraduate training included an internship and residency in urology at the Good Samaritan Hospital in Cincinnati. He subsequently completed a genitourinary cancer fellowship at the University of California Medical Center in Los Angeles.
  • Comparing Automated Microscopy Data to Manual Review
    Comparing Automated Microscopy Data to Manual Review Dr. Michael Samoszuk Recorded: Jan 11 2017 26 mins
    Are you having difficulty categorizing urine sediment particles due to operator subjectivity?

    Automating urine sediment microscopy can help standardize particle characterization. In the final installment of our miniseries, Dr. Michael Samoszuk presents automated and manual microscopy study data from Dr. Sorin Gîju, clinical chemist at the Clinical Emergency Hospital in Timisoara, Romania.

    Dr. Samoszuk compares results from the iRICELL3000 automated microscopy system and manual microscopy for the same patient samples. The iRICELL3000’s proprietary Digital Flow Morphology technology captures 500 images per sample and offers 12-particle classification, resulting in fewer opportunities to miss urine particles.

    Watch this webinar to enhance your understanding of your urinalysis results.

    Presenter:
    Dr. Michael Samoszuk, M.D., vice president and chief medical officer of Beckman Coulter Diagnostics is a graduate of Harvard Medical School, Boston, and completed his postgraduate training at Brigham and Women's Hospital, Boston; University of California, San Francisco; and University of Southern California, Los Angeles. As an experienced chief medical officer, director of hemapathology and associate professor of pathology and radiology, Dr. Samoszuk contributes his expertise to Beckman Coulter’s diagnostics division. His guidance supports product and process developments as well as performance enhancements with patients and clinicians in mind.
  • Achieve Better Hematology Quality Control with Bulls X̄B
    Achieve Better Hematology Quality Control with Bulls X̄B Dr. Guido Vranken and Lobke Tremmerie Recorded: Dec 13 2016 50 mins
    Dr. Guido Vranken and Lobke Tremmerie discuss how to implement Bulls XB algorithm, which uses RBC indices to create a weighted moving average of patient sample results, to statistically monitor hematology results. This unique algorithm, offered on Beckman Coulter hematology instruments, allows users to monitor result quality without additional reagents, software licenses or costs. Laboratories worldwide can implement this simple, powerful tool to enhance results and improve compliance.

    P.A.C.E. credit is available for your participation.*

    Presenters: Guido Vranken, Ph.D, has been working with customers for over 30 years across different disciplines, including protein chemistry, immunoassay and hematology. He specializes in conducting internal and external validation studies. Dr. Vranken spent three years as a lecturer on statistics at the University of Ghent. Lobke Tremmerie earned her environmental engineering degree from the University of Ghent in 2002. She first became an electrophoresis and nephelometry sales engineer at Analis, Beckman Coulter’s exclusive Belgian distributor. Following her true passion, she transferred into the hematology division in 2004. Ms. Tremmerie currently serves as Analis’ cellular biology product marketing manager.
  • Adjusting Data Parameters to Improve Results and Workflow
    Adjusting Data Parameters to Improve Results and Workflow Dr. Michael Samoszuk Recorded: Dec 7 2016 18 mins
    How do you know when your result parameters are set to their most efficient ranges?

    In part two of our three-part webinar series, Dr. Michael Samoszuk highlights the correlative relationships between urine chemistry data and urine microscopy data on Beckman Coulter’s Iris iRICELL3000. Learn how these correlations can help you optimize the customizable auto-release function and reduce your laboratory’s manual workload.

    Presenter:
    Michael Samoszuk, M.D., vice president and chief medical officer of Beckman Coulter Diagnostics, is a graduate of Harvard Medical School, Boston, and completed his postgraduate training at Brigham and Women's Hospital, Boston; University of California, San Francisco; and University of Southern California, Los Angeles. As an experienced chief medical officer, director of hemapathology and associate professor of pathology and radiology, Dr. Samoszuk contributes his expertise to Beckman Coulter’s diagnostics division. His guidance supports product and process developments as well as performance enhancements with patients and clinicians in mind.
  • Red Blood Cell Data Correlation between Urinalysis Methods
    Red Blood Cell Data Correlation between Urinalysis Methods Dr. Michael Samoszuk Recorded: Nov 16 2016 21 mins
    What does it mean when you have positive urine chemistry red blood cell (RBC) results but see no RBCs under the microscope?

    In part one of our webinar series, Dr. Michael Samoszuk illustrates which properties of RBCs interact chemically with iRICELL3000 urine test strips to cause positive urine chemistry results, even in the absence of whole RBCs under the microscope.

    Watch this webinar to learn more about the cause of contrasting results between urine chemistry and urine microscopy and understand why your results may still be in perfect correlation.

    Presenter:
    Michael Samoszuk, M.D., vice president and chief medical officer of Beckman Coulter Diagnostics, is a graduate of Harvard Medical School, Boston, and completed his postgraduate training at Brigham and Women's Hospital, Boston; University of California, San Francisco; and University of Southern California, Los Angeles. As an experienced chief medical officer, director of hemapathology and associate professor of pathology and radiology, Dr. Samoszuk contributes his expertise to Beckman Coulter’s Diagnostics His guidance supports product and process developments as well as performance enhancements with patients and clinicians in mind.
  • Emerging Topics in Antibiotic Resistance
    Emerging Topics in Antibiotic Resistance Barbara Zimmer, Ph.D. Recorded: Oct 12 2016 58 mins
    In this webinar, Dr. Barbara Zimmer will discuss the mechanisms of antibiotic resistance that are most concerning to the Centers for Disease Control (CDC). Attendees will receive an in-depth review of the classes of beta-lactamase resistance found in Enterobacteriaceae and the challenges associated with detection in the laboratory. P.A.C.E. credit is available for your participation.*
  • A Simple Blood Test for Better Prostate Cancer Detection
    A Simple Blood Test for Better Prostate Cancer Detection Dr. Vernon Mustoe Recorded: Oct 5 2016 59 mins
    Prostate cancer is the most common cancer among men. Fortunately, it can be detected early by monitoring PSA levels. However, PSA tests have limited specificity for cancer, resulting in numerous unnecessary biopsies each year, which creates the need for a more precise test to help with prostate cancer detection. In this webinar, Dr. Vernon Mustoe will discuss how a simple blood test can help provide more accurate information on what an elevated PSA level might mean and the probability of finding prostate cancer on biopsy. P.A.C.E. credit is available for your participation.*

    Dr. Vernon Mustoe is one of Beckman Coulter’s medical affairs managers, supporting customers with advanced clinical and technical issues. Having obtained his undergraduate and graduate degrees from New York University, he spent over 23 years in the clinical laboratory. Most recently, he was the Director of Clinical Chemistry and Assistant Director of Laboratory Services at Sisters of Charity Medical Center in Staten Island, N.Y. He has also taught Clinical Pathology at the Bayley Seton Physician Assistant School, as well as Clinical and Anatomic Pathology at the College of Staten Island Campus of the City University of New York. Dr. Mustoe has been with Beckman Coulter since 2001.
  • Improve Lymphocytosis Management for Hematopathology Patients
    Improve Lymphocytosis Management for Hematopathology Patients Dr. Mikael Roussel Recorded: Sep 21 2016 59 mins
    Dr. Mikael Roussel discusses the organization of the cell morphology and flow cytometry core laboratory. In addition, he also speaks about differentiating reactive lymphocytes from malignant lymphocytes for improved management of patients with lymphocytosis. Hear his experience leveraging the CytoDiff* reagent system as a supplement to primary analysis on the DxH 800 analyzer. View this webinar to:

    - Learn how to save time, labor and money while increasing staff satisfaction
    - Hear how to avoid unnecessary slide reviews when samples are flagged for the presence of immature granulocytes
    - Participate in a Q&A with a senior staff member who offers more than 12 years of cellular hematology and flow cytometry experience

    P.A.C.E. credit is available for your participation.**

    Presenter: Mikael Roussel, M.D., Ph.D., works in the hematology laboratory at the University Hospital of Rennes, France, and has more than 12 years of experience in cellular hematology and flow cytometry. As a senior staff member in the cell morphology and flow cytometry core laboratory, Dr. Roussel supervises 2,000 flow cytometric analyses per year. His areas of interest include flow cytometry, single cell analysis, lymphomas, minimal residual disease, hematological malignancies (chronic and acute), laboratory automation and computational biology.

    *CE marked; not available for sale in the U.S and other geographies.
  • New Methods for Flow WBC Differential
    New Methods for Flow WBC Differential Dr. Francis Lacombe, M.D., Ph.D., Université Hôpital, Haut-Lévêque, Pessac, France Recorded: Jun 29 2016 61 mins
    Dr. Francis Lacombe explains how Beckman Coulter's HematoFlow* and CytoDiff* were instrumental to a recent study that tracked blast decrease rates in acute myeloid leukemia (AML) patients. In addition to the results of this study, Dr. Lacombe will discuss:

    - Limitations of the existing reference method (microscopy) for WBC differential
    - Key functionality and benefits of HematoFlow and CytoDiff
    - How CytoDiff enables efficient, accurate blast count

    P.A.C.E. credit is available for your participation.**

    Presenter: Francis Lacombe, M.D., Ph.D., is head of the hematology/automation laboratory and director of flow cytometry at the Université Hôpital, Haut-Lévêque, Pessac, France. Dr. Lacombe serves as a member of Société Française d'Hématologie, Groupe Français d'Hématologie Cellulaire, Association Française de Cytométrie and Groupe d'Etude Immunologique des Leucémies; a counselor for the International Society for Analytical Cytology and the International Society for Laboratory Hematology; an advisor to the CLSI Hematology committee; and an ICSH member.

    *CE marked; not available for sale in the U.S and other geographies.
  • Lean High-volume Hematology Solutions
    Lean High-volume Hematology Solutions Alan Neal, CSci, MSc, FIBMS, quality manager and lead of specialty, hematology, at Pathology Associates Recorded: Apr 19 2016 65 mins
    Alan Neal explains how Beckman Coulter’s Lean high-volume hematology solutions can improve laboratory efficiency and help deliver better patient care. Learn how his laboratory implemented Beckman Coulter automation and Lean manufacturing principles to:

    - Standardize procedures, improve quality and reduce costs
    - Meet high demand while delivering consistent turnaround times
    - Reduce manual intervention and achieve high auto-validation rates

    P.A.C.E. credit for this webinar is no longer available.*

    Presenter: Alan Neal, CSci, MSc, FIBMS, is the quality manager and lead of specialty for Hematology Pathology Associates. He has more than 30 years of experience as a scientist and laboratory manager. In addition to his roles at Pathology Associates, he serves as a charge scientist at Pathlab Waikato and a technical adviser with the Medical Testing Professional Advisory Committee at International Accreditation New Zealand.

Embed in website or blog